Cabot Corporation
General ticker "CBT" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $4.3B (TTM average)
Cabot Corporation does not follow the US Stock Market performance with the rate: -6.3%.
Estimated limits based on current volatility of 1.3%: low 72.47$, high 74.43$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-02-27, amount 0.45$ (Y2.42%)
- Total employees count: 4200 (-2.3%) as of 2024
- China accounted for 24.6% of revenue in the fiscal year ended 2024-09-30
- US accounted for 18.4% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: China operations risks, Market competition, Regulatory and compliance, Geopolitical risks, Operational and conduct risks
- Current price 24.8% below estimated low
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [92.50$, 131.30$]
- 2025-09-30 to 2026-09-30 estimated range: [98.92$, 139.97$]
Financial Metrics affecting the CBT estimates:
- Negative: with PPE of 15.6 at the end of fiscal year the price was high
- Positive: 7.68 < Operating profit margin, % of 15.37
- Positive: 6.68 < Operating cash flow per share per price, % of 11.60
- Positive: 0.25 < Industry earnings per price (median), % of 2.06
- Positive: 19.49 < Shareholder equity ratio, % of 38.14 <= 42.60
- Positive: 3.02 < Industry operating profit margin (median), % of 4.89
- Positive: Interest expense per share per price, % of 1.36 <= 3.29
- Positive: Industry inventory ratio change (median), % of -0.19 <= -0.15
- Positive: Return on assets ratio (scaled to [-100,100]) of 10.06 > 6.12
Short-term CBT quotes
Long-term CBT plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $4,345.00MM | $3,931.00MM | $3,994.00MM |
| Operating Expenses | $3,956.00MM | $3,405.00MM | $3,380.00MM |
| Operating Income | $389.00MM | $526.00MM | $614.00MM |
| Non-Operating Income | $-54.00MM | $-75.00MM | $-85.00MM |
| Interest Expense | $56.00MM | $90.00MM | $81.00MM |
| R&D Expense | $55.00MM | $57.00MM | $63.00MM |
| Income(Loss) | $335.00MM | $451.00MM | $529.00MM |
| Taxes | $102.00MM | $-28.00MM | $111.00MM |
| Other Income(Loss) | $10.00MM | $5.00MM | $6.00MM |
| Profit(Loss)* | $209.00MM | $445.00MM | $380.00MM |
| Stockholders Equity | $898.00MM | $1,264.00MM | $1,425.00MM |
| Inventory | $664.00MM | $585.00MM | $552.00MM |
| Assets | $3,525.00MM | $3,604.00MM | $3,736.00MM |
| Operating Cash Flow | $100.00MM | $595.00MM | $692.00MM |
| Capital expenditure | $211.00MM | $244.00MM | $241.00MM |
| Investing Cash Flow | $-118.00MM | $-214.00MM | $-235.00MM |
| Financing Cash Flow | $145.00MM | $-403.00MM | $-415.00MM |
| Earnings Per Share** | $3.72 | $8.06 | $7.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.